These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19853975)

  • 21. Liver support by extracorporeal blood purification: a clinical observation.
    Stange J; Mitzner SR; Klammt S; Freytag J; Peszynski P; Loock J; Hickstein H; Korten G; Schmidt R; Hentschel J; Schulz M; Löhr M; Liebe S; Schareck W; Hopt UT
    Liver Transpl; 2000 Sep; 6(5):603-13. PubMed ID: 10980060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of plasma protein binding, volume of distribution and molecular weight on the fraction of drugs eliminated by hemodialysis.
    Keller F; Wilms H; Schultze G; Offerman G; Molzahn M
    Clin Nephrol; 1983 Apr; 19(4):201-5. PubMed ID: 6851257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
    Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA
    Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amphotericin B removal by plasma exchange.
    Lew SQ
    J Clin Pharm Ther; 2009 Feb; 34(1):115-7. PubMed ID: 19125909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosage adjustment of antiinfective therapy in patients with renal impairment.
    Eckhardt A; Borner K; Keller F; Zellner D
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):99-102. PubMed ID: 9088997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial agents in renal failure.
    Livornese LL; Benz RL; Ingerman MJ; Santoro J
    Infect Dis Clin North Am; 1995 Sep; 9(3):591-614. PubMed ID: 7490435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Adjusting dosage of drugs in patients with kidney or liver failure].
    Krähenbühl S
    Schweiz Med Wochenschr; 1998 Feb; 128(6):189-94. PubMed ID: 9540139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study to evaluate the pharmacokinetics of oral 5-fluorouracil and eniluracil after concurrent administration to patients with refractory solid tumours and varying degrees of renal impairment (FUMA1005).
    O'Donnell A; Punt CJ; Judson I; Van Maanen L; Suttle AB; Ertel P; Beale P
    Cancer Chemother Pharmacol; 2003 Jan; 51(1):58-66. PubMed ID: 12497207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis.
    Czock D; Hüsig-Linde C; Langhoff A; Schöpke T; Hafer C; de Groot K; Swoboda S; Kuse E; Haller H; Fliser D; Keller F; Kielstein JT
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1263-8. PubMed ID: 17699357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of antibacterial agents in renal failure.
    Gilbert B; Robbins P; Livornese LL
    Infect Dis Clin North Am; 2009 Dec; 23(4):899-924, viii. PubMed ID: 19909890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and/or renal clearance.
    Borchard U
    Clin Physiol Biochem; 1990; 8 Suppl 2():28-34. PubMed ID: 1982759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug therapy of bacterial infections in the aged].
    Shimada K
    Nihon Naika Gakkai Zasshi; 1990 Dec; 79(12):1641-5. PubMed ID: 2079587
    [No Abstract]   [Full Text] [Related]  

  • 34. Determination of antibiotic dosage adjustments in patients with renal impairment: elements for success.
    Patel N; Scheetz MH; Drusano GL; Lodise TP
    J Antimicrob Chemother; 2010 Nov; 65(11):2285-90. PubMed ID: 20736235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Individualization of drug therapy in renal or liver insufficiency].
    Martin-Facklam M
    Ther Umsch; 2000 Sep; 57(9):568-72. PubMed ID: 11036437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing patterns of hospital infections: implications for therapy. Changing concepts and new applications of antibiotic pharmacokinetics.
    Craig WA; Vogelman B
    Am J Med; 1984 Jul; 77(1B):24-8. PubMed ID: 6380283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic pharmacokinetics and clinical application in renal insufficiency.
    Whelton A
    Med Clin North Am; 1982 Jan; 66(1):267-81. PubMed ID: 7038334
    [No Abstract]   [Full Text] [Related]  

  • 38. Proceedings: Netherlands Society for Microbiology meeting at Utrecht on 2 May 1973. The clearance of antibiotics by the artificial kidney.
    Verhoef J; Oe PL; Simonian S
    Antonie Van Leeuwenhoek; 1973 Nov; 39(4):654. PubMed ID: 4543761
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antibiotic dosage in renal failure].
    Lüthy R; Siegenthaler W
    Schweiz Med Wochenschr; 1973 May; 103(20):740-3. PubMed ID: 4702991
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of molybdenum in chronic hemodialysis patients.
    Hosokawa S; Yoshida O
    Int J Artif Organs; 1994 Nov; 17(11):567-9. PubMed ID: 7744513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.